Sunday, September 27, 2020

Could Stem Cell Therapy Eliminate the Need for Immunosuppressant in Kidney Transplant?

According to Dr. Samuel Strober, an immunologist and professor of medicine at Stanford, stem cells therapy could potentially eliminate the need for long term use of immunosuppressant therapy such as prograf, prednisone, cellcept, etc. They have enrolled 12 patients who underwent perfect match kidney transplant. A perfect match would be a kidney received from a living donor which most likely is a relative. Out of those 12 patients, 8 of them have been off immunosuppressant for at least a year and up to 3 years.

This new treatment did not happen overnight. Dr. Strober has done extensive research for the past 30 years and his method includes a mix of radiation, donor

Stem cells and antibodies. All three techniques are used to weaken the immune system. The treatment starts as early as the kidney transplant recipient is stable enough. It can be as early as a few days after the surgery. The first phase is to use radiation against some lymph nodes, the spleen and thymus gland. The goal is to weaken the immune system temporarily.

About 10 days later, time comes for the donor stem cells injection. This one is done as outpatient. To be noted that during this early phase of treatment immunosuppressant therapy is still being given to prevent rejection. The cells injections have for effect to help the kidney transplant recipient’s immune system blend with the new organ so it does not attack it. The body will get used to the new kidney and eventually consider it as friendly.

During this whole process transplant medications are weaned off as tolerated. They monitor signs of rejection which includes decreased kidney function. So far, according to the small study, 67% of the patients have successfully been weaned from immunosuppressant therapy. That is a very small number but I believe it is a promising treatment.

The long term benefits are numerous is this can be done more widespread with a high success rate. Because the transplant medications themselves can cause kidney failure, stem cell therapy could potentially prevent a second kidney transplant for several patients and thus making more organs available for transplantation. There are other risks associated with regular transplant medicines like skin cancer, diabetes, heart disease to name a few. Basically, patients could live longer with a better quality of life.

Pierre Luc Charland
Pierre Luc Charland
Aside from being a very experienced transplant coordinator in the Houston area, Pierre is also an amazing content creator for our properties. Pierre plays a key role in driving our mission and offering expert insight to the ever evolving world of transplantation.

Facebook Comments


Must Read

PIO who cured man of HIV now takes on Covid

Transplant News Sharing // News from Source MELBOURNE: In February, when Ravindra Gupta, an Indian-origin professor at the University of Cambridge Institute for Therapeutic...

Memorial Transplant Institute Performs Its 100th Kidney Transplant: Notes & News: South Florida Hospital News

Transplant News Sharing // News from Source COVID-19 has not deterred the team of experts at Memorial Transplant Institute who recently performed its 100th...

Westchester Medical Center celebrates 300th heart transplant despite pandemic

Transplant News Sharing // News from Source News 12 StaffSep 24, 2020, 11:28pm EDTUpdated on:Sep 24, 2020, 11:28pm EDTThe Westchester Medical Center surpassed its...

Selena Gomez shows off kidney transplant scar in swimwear shot | Ents & Arts News

Transplant News Sharing // News from Source Selena Gomez has revealed a scar on her inner thigh, which was left following a kidney transplant...

FAQs About Liver Transplant for FAP

Transplant News Sharing // News from Source Familial amyloid polyneuropathy (FAP) is a rare genetic disease caused by a mutation in the TTR gene....